Dokument: Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering
| Titel: | Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering | |||||||
| URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=67647 | |||||||
| URN (NBN): | urn:nbn:de:hbz:061-20241122-093052-7 | |||||||
| Kollektion: | Publikationen | |||||||
| Sprache: | Englisch | |||||||
| Dokumententyp: | Wissenschaftliche Texte » Artikel, Aufsatz | |||||||
| Medientyp: | Text | |||||||
| Autoren: | Nelke, Christopher [Autor] Schroeter, Christina B. [Autor] Barman, Sumanta [Autor] Stascheit, Frauke [Autor] Masanneck, Lars [Autor] Theissen, Lukas [Autor] Huntemann, Niklas [Autor] Walli, Sara [Autor] Cengiz, Derya [Autor] Dobelmann, Vera [Autor] | |||||||
| Dateien: |
| |||||||
| Stichwörter: | Complement inhibition, Myasthenia gravis, Complement, Proteomics, Consensus clustering | |||||||
| Beschreibung: | Background
The clinical heterogeneity of myasthenia gravis (MG), an autoimmune disease defined by antibodies (Ab) directed against the postsynaptic membrane, constitutes a challenge for patient stratification and treatment decision making. Novel strategies are needed to classify patients based on their biological phenotypes aiming to improve patient selection and treatment outcomes. Methods For this purpose, we assessed the serum proteome of a cohort of 140 patients with anti-acetylcholine receptor-Ab-positive MG and utilised consensus clustering as an unsupervised tool to assign patients to biological profiles. For in-depth analysis, we used immunogenomic sequencing to study the B cell repertoire of a subgroup of patients and an in vitro assay using primary human muscle cells to interrogate serum-induced complement formation. Findings This strategy identified four distinct patient phenotypes based on their proteomic patterns in their serum. Notably, one patient phenotype, here named PS3, was characterised by high disease severity and complement activation as defining features. Assessing a subgroup of patients, hyperexpanded antibody clones were present in the B cell repertoire of the PS3 group and effectively activated complement as compared to other patients. In line with their disease phenotype, PS3 patients were more likely to benefit from complement-inhibiting therapies. These findings were validated in a prospective cohort of 18 patients using a cell-based assay. Interpretation Collectively, this study suggests proteomics-based clustering as a gateway to assign patients to a biological signature likely to benefit from complement inhibition and provides a stratification strategy for clinical practice. Funding CN and CBS were supported by the Forschungskommission of the Medical Faculty of the Heinrich Heine University Düsseldorf. CN was supported by the Else Kröner-Fresenius-Stiftung (EKEA.38). CBS was supported by the Deutsche Forschungsgemeinschaft (DFG–German Research Foundation) with a Walter Benjamin fellowship (project 539363086). The project was supported by the Ministry of Culture and Science of North Rhine-Westphalia (MODS, “Profilbildung 2020” [grant no. PROFILNRW-2020–107-A]). | |||||||
| Rechtliche Vermerke: | Originalveröffentlichung:
Nelke, C., Menskes, C. B., Barman, S., Stascheit, F., Masanneck, L., Theissen, L., Huntemann, N., Walli, S., Cengiz, D., Dobelmann, V., Vogelsang, A., Pawlitzki, M., Räuber, S., Konen, F. F., Skripuletz, T., Hartung, H.-P., König, S., Roos, A., Meisel, A., … Ruck, T. (2024). Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering. EBioMedicine, 105, Article 105231. https://doi.org/10.1016/j.ebiom.2024.105231 | |||||||
| Lizenz: |  Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
| Fachbereich / Einrichtung: | Mathematisch- Naturwissenschaftliche Fakultät Medizinische Fakultät | |||||||
| Dokument erstellt am: | 22.11.2024 | |||||||
| Dateien geändert am: | 22.11.2024 |
